Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.95 | N/A |
| PEG Ratio (TTM) | -0.32 | N/A |
| P/S Ratio (TTM) | 6.78 | N/A |
| P/B Ratio (TTM) | 0.98 | N/A |
| P/FCF Ratio (TTM) | 23.06 | N/A |
| Price to 5YR AVG Earnings Ratio | 21.55 | N/A |
| Price to 5YR AVG FCF Ratio | 6.68 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.27% | N/A |
| ROE (TTM) | 12.39% | N/A |
| Net Profit Margin (TTM) | 85.26% | N/A |
| ROIC 5YR AVG | 3.05% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -19.10% | 157.16% | 100.02% |
| Revenue | -1.77% | 168.16% | 111.01% |
| Net Income | -19.08% | 237.86% | 149.27% |
| Cash Flow | 734.90% | 26.75% | 481.00% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.22 | N/A |
| Quick Ratio (TTM) | 0.22 | N/A |
| D/E Ratio (TTM) | 0.47 | N/A |
| Interest Coverage (TTM) | 8.33 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.55 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -3.05% | N/A |